Key facts
- Notable investors include Harvard Innovation Launch Lab, Eos BioInnovation, Panacea Capital (California).
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Lightning Biotherapeutics
- ·The full record, as it builds
Funding rounds
No funding rounds for Lightning Biotherapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Lightning Biotherapeutics
Developer of immunological therapeutic systems designed for the restoration of immune function. The company is currently operating in Stealth mode.
- Sector
- Healthcare
- HQ
- Boston, MA, United States
- Ownership
- Privately Held (backing)
Lightning Biotherapeutics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Lightning Biotherapeutics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Lightning Biotherapeutics in its N-PORT filings yet. We sweep new filings monthly.